Home / Inspections / 1068081

FDA Inspection 1068081 — Abbott Molecular, Inc.

Abbott Molecular, Inc. — FEI 3005248192

The FDA completed an inspection of Abbott Molecular, Inc. on September 20, 2018 in Des Plaines, IL. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
September 20, 2018
Fiscal Year
2018
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Des Plaines, IL (United States)

Facility

Other inspections at this facility

  • 1195852 (VAI Fri Jan 27 2023 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1136769 (NAI Fri Feb 19 2021 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1098947 (NAI Wed Jul 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1013090 (NAI Thu May 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 964027 (NAI Thu Mar 31 2016 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources